| NCT05668585 | A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 | 2022-12-08 | 2027-04-11 | 2027-03-11 |
| NCT05355753 | A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors | TERMINATED | PHASE1 | 2022-03-25 | 2023-12-19 | 2023-12-19 |
| NCT04756726 | Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma | ACTIVE_NOT_RECRUITING | PHASE1 | 2021-04-27 | 2026-03-31 | 2025-12-31 |